BPIQ Blog

Apr 29, 20195 min read

FDA Decision on Heron's Non-Opioid Pain Med Imminent

We think Heron (HRTX) has a very good chance of approval by the FDA by the April 30, 2019 due date for its non-opioid pain med HTX-011....

Mar 12, 20191 min read

Yesterday, Heron (HRTX) reported additional data for its opioid-free pain med candidate HTX-011 in a post-surgery setting. In the latest...

Our platform helps you uncover your next biotech investment opportunity